Related Experiment Video
Updated: Jan 17, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
New nicotine products and vascular risk
R Córdoba García1, V Barchilon Cohen2, J Lozano Fernández3
1Facultad de Medicina, Centro de Salud Delicias Sur, Zaragoza, Spain.
Novel nicotine products may pose less vascular risk than cigarettes, but they do not reduce overall harm. Dual use, relapse, delayed cessation, and youth initiation are significant concerns with these products.
Area of Science:
- Public Health
- Cardiovascular Disease Research
- Tobacco Control
Background:
- Tobacco use is a primary cause of preventable mortality in Spain, contributing to significant cardiovascular disease burden.
- Emerging novel nicotine products present a complex challenge in understanding their impact on public health and smoking cessation.
Purpose of the Study:
- To review the association between novel nicotine product use and vascular/health risks.
- To evaluate the impact of novel products on smoking cessation and harm reduction strategies.
Main Methods:
- Conducted comprehensive literature searches across multiple databases including PubMed, Tripadatabase.com, and industry document repositories.
- Analyzed evidence regarding vascular, cardiorespiratory, and metabolic risks associated with novel nicotine products compared to traditional cigarettes.
Main Results:
- Some evidence suggests novel products may have lower vascular, cardiorespiratory, and metabolic harm than individual cigarettes.
- No evidence supports that replacing cigarettes with novel nicotine products reduces overall harm due to dual use, relapse, delayed cessation, and youth uptake.
Conclusions:
- Novel nicotine products do not currently demonstrate a reduction in overall harm compared to cigarettes.
- Concerns regarding dual smoking, relapse, delayed cessation, and initiation among minors highlight the need for continued research and regulatory oversight.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
CNS Depressants: Alcohol and Nicotine
Relative Risk
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...